A phase I trial of imatinib (IM) plus mFOLFOX-bevacizumab in patients with advanced colorectal cancer.
M. Michael
No relevant relationships to disclose
N. C. Tebbutt
Consultant or Advisory Role - Roche (U)
Research Funding - Novartis
P. Gibbs
No relevant relationships to disclose
L. R. Lipton
No relevant relationships to disclose
M. Jefford
No relevant relationships to disclose
A. Milner
No relevant relationships to disclose
M. Gouillou
No relevant relationships to disclose
A. Hatzimihalis
No relevant relationships to disclose
G. A. McArthur
Consultant or Advisory Role - Novartis (U)
J. R. Zalcberg
No relevant relationships to disclose